サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1481977

北米の微生物同定法：2030年までの市場予測 - 地域分析 - 方法、タイプ別

North America Microbial Identification Methods Market Forecast to 2030 - Regional Analysis - By Method and Type

出版日
ページ情報
英文 96 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
北米の微生物同定法：2030年までの市場予測 - 地域分析 - 方法、タイプ別
出版日: 2024年02月28日
発行: The Insight Partners
ページ情報: 英文 96 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の微生物同定法市場は、2022年に21億1,183万米ドルと評価され、2030年には33億1,978万米ドルに達すると予測され、2022年から2030年までのCAGRは5.8%で成長すると予測されています。

微生物同定手順を求める食品安全への関心の高まりが北米の微生物同定法市場を後押し

食品媒介感染症（FBD）は、公衆衛生および経済問題の蔓延・拡大です。食品媒介感染症の流行は、最近の食品生産・加工方法の変化と消費者の進化し続ける食事パターンの影響を受けています。感染時の既知の病原体間の相互作用は懸念事項の一つであり、近年新たな難題が浮上しています。化学保存料やコールドチェーンの採用が進み、微生物に対する理解が深まっているにもかかわらず、食中毒は先進国、発展途上国双方にとって重大な公衆衛生問題です。フード・セキュリティ・クラスターは、毎年42万人が死亡し、6億人以上（世界のほぼ10人に1人）が汚染された食品を摂取した後に病気になり、2022年6月には3,300万DALYが失われると推定しています。

米国疾病予防管理センター（CDC）の2019年版によると、米国では毎年約6人に1人が食中毒に罹患しています。サルモネラ、大腸菌、カンピロバクター、リステリアなどの細菌が多くの食中毒の原因です。食中毒は、国内で毎年約10万人の入院患者と3,000人の死亡者を出しています。さらに、毎年400万人のカナダ人、つまり人口の8人に1人が汚染された食品によって病気になります。年間推定11,500人が入院し、240人が死亡しています。この数字には、30種類の食中毒病原体と、急性胃腸炎の未確認原因の両方が含まれています。従来のアプローチは、様々な非選択的・選択的濃縮技術を用いて細菌を培養し、生化学的確認などを行うものでした。食品、特に生肉、魚、乳製品、野菜など保存期間の短いものを検査する場合、検出までの時間が大きな制約となります。いくつかの新しい検出方法は、マトリックス支援レーザー脱離イオン化飛行時間法やハイパースペクトル画像法などの分光学的アプローチを用いています。このように、食中毒事例の増加が微生物同定法市場を牽引しています。

北米の微生物同定法市場概要

北米の微生物同定法市場は、ヘルスケア、医薬品、飲食品、環境モニタリングなどさまざまな産業で正確かつ迅速な微生物同定に対する需要が急増したため、過去数年間で大幅な成長を遂げています。この成長の背景には、感染症の発生率の上昇、食品や医薬品の生産における厳格な品質管理対策の必要性、公衆衛生の維持における微生物モニタリングの重要性に対する意識の高まりなど、いくつかの要因があります。CDCが2022年11月に発表した最新情報によると、冷凍コロッケに関連して発生した大腸菌感染アウトブレイクでは、20件の発病者と5件の入院者を出しました。

さらに、技術の進歩、革新的な微生物同定法のイントロダクション、重要なプレイヤーの存在が、今後数年間の市場拡大をサポートすると予想されています。例えば、微生物学細菌同定検査の準備を自動化することを目的としたBD Kiestra IdentifAシステムは、2022年1月にFDAから510（k）認可を受けた。また、米国のBruker Corporationは2021年1月、MALDI Biotyper CAシステムを用いて陽性血液培養から425以上の細菌を迅速に同定するMBT Sepsityper Kit IVDを発表しました。さらに、自動化と人工知能（AI）は、同定プロセスを合理化し、人的ミスを減らし、全体的な効率を向上させる上で極めて重要です。製薬およびバイオテクノロジー部門は、北米の微生物同定市場の成長に大きく貢献しています。医薬品開発、品質管理、規制遵守のために微生物を正確に同定する必要があるため、高度な同定方法に対する需要が高まっています。このように、様々なエンドユーザーにおける正確かつ迅速な微生物同定に対する需要の増加、感染症の発生率の上昇、食品および医薬品製造における厳格な品質管理対策の必要性、公衆衛生の維持における微生物モニタリングの重要性に対する意識の高まりは、北米の市場を牽引する他のいくつかの要因です。

北米の微生物同定法市場の収益と2030年までの予測（金額）

北米の微生物同定法市場のセグメンテーション

北米の微生物同定法市場は、方法、タイプ、国によって区分されます。

手法に基づき、北米の微生物同定法市場は遺伝子型、表現型、プロテオ型に区分されます。2022年には、表現型セグメントが最大のシェアを占めています。遺伝子型セグメントはさらに機器、キット、試薬に細分化されます。表現型セグメントはさらに機器、キット、試薬に細分化されます。プロテオタイプのセグメントはさらに機器、キット、試薬に細分化されます。

タイプ別では、北米の微生物同定法市場は細菌同定システム、微生物列挙システム、耐性菌同定システム、微生物学アナライザー、その他に区分されます。細菌同定システムセグメントが2022年に最大のシェアを占めました。

国別では、北米の微生物同定法市場は米国とカナダに二分されます。米国は2022年に北米の微生物同定法市場を独占しました。

Accelerate Diagnostics Inc、Avantor Inc、Becton Dickinson and Co、bioMerieux SA、Bruker Corp、Danaher Corp、Merck KGaA、Molzym GmbH &Co KG、Shimadzu Corp、Thermo Fisher Scientific Incは、北米の微生物同定法市場で事業展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の微生物同定法の市場情勢

  • 北米のPEST分析

第5章 北米の微生物同定法市場-主要産業力学

  • 市場促進要因
    • 微生物同定法を求める食品安全への関心の高まり
    • 様々なエンドユーザーにおける微生物同定法に対する需要の高まり
  • 市場抑制要因
    • 自動微生物同定システムの高コスト
    • 複雑な規制枠組みによる新規微生物診断検査の承認プロセスの遅延
  • 市場機会
    • 微生物同定を促進するための政府の取り組みと資金援助
  • 今後の動向
    • 微生物同定技術の進歩
  • 影響分析

第6章 微生物同定法市場：北米市場分析

  • 北米の微生物同定法市場収益、2020年～2030年

第7章 北米の微生物同定法市場 - 収益と2030年までの予測：微生物同定法別

  • 市場収益シェア、2022年および2030年
  • 遺伝子型
  • 表現型
  • プロテオタイピック

第8章 北米の微生物同定法市場 - 収益と2030年までの予測：タイプ別

  • 市場収益シェア、2022年および2030年
  • 細菌同定システム
  • 微生物同定システム
  • 耐性菌同定システム
  • 微生物分析装置
  • その他

第9章 北米の微生物同定法市場：国別分析

  • 北米
    • 米国
    • カナダ

第10章 北米の微生物同定法市場の業界情勢

  • 北米の微生物同定法市場の成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • Avantor Inc
  • Becton Dickinson and Co
  • Danaher Corp
  • bioMerieux SA
  • Merck KGaA
  • Thermo Fisher Scientific Inc
  • Bruker Corp
  • Shimadzu Corp
  • Accelerate Diagnostics Inc
  • Molzym GmbH & Co KG
  • Biolog Inc

第12章 付録

図表

List Of Tables

  • Table 1. North America Microbial Identification Methods Market Segmentation
  • Table 2. North America Microbial Identification Methods Market, by Genotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Microbial Identification Methods Market, by Genotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Microbial Identification Methods Market, by Phenotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America Microbial Identification Methods Market, by Phenotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America Microbial Identification Methods Market, by Proteotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. North America Microbial Identification Methods Market, by Proteotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US: North America Microbial Identification Methods Market Revenue And Forecast to 2030 (US$ Mn) - Methods
  • Table 9. US: North America Microbial Identification Methods Market, by Genotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US: North America Microbial Identification Methods Market, by Genotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US: North America Microbial Identification Methods Market, by Phenotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. US: North America Microbial Identification Methods Market, by Phenotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. US: North America Microbial Identification Methods Market, by Proteotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. US: North America Microbial Identification Methods Market, by Proteotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. US: North America Microbial Identification Methods Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 16. Canada: North America Microbial Identification Methods Market Revenue And Forecast to 2030 (US$ Mn) - Method
  • Table 17. Canada: North America Microbial Identification Methods Market, by Genotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Canada: North America Microbial Identification Methods Market, by Genotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Canada: North America Microbial Identification Methods Market, by Phenotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Canada: North America Microbial Identification Methods Market, by Phenotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Canada North America Microbial Identification Methods Market, by Proteotypic Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Canada: North America Microbial Identification Methods Market, by Proteotypic Microbe Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Canada: North America Microbial Identification Methods Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 24. Recent Inorganic Growth Strategies in the North America Microbial Identification Methods Market
  • Table 25. Recent Organic Growth Strategies in the North America Microbial Identification Methods Market
  • Table 26. Glossary of Terms, North America Microbial Identification Methods Market

List Of Figures

  • Figure 1. North America Microbial Identification Methods Market Segmentation, By Country
  • Figure 2. North America - PEST Analysis
  • Figure 3. North America Microbial Identification Methods Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Microbial Identification Methods Market Revenue (US$ Mn), 2020 - 2030
  • Figure 6. North America Microbial Identification Methods Market Revenue Share, by Method 2022 & 2030 (%)
  • Figure 7. Genotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Phenotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Proteotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. North America Microbial Identification Methods Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 11. Bacterial Identification System: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Microbial Enumeration System: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Bacterial Resistance Identification Systems: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Microbiology Analyzer: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. North America Microbial Identification Methods Market, 2022 ($Mn)
  • Figure 17. North America Microbial Identification Methods Market, By Key Countries, 2022 And 2030 (%)
  • Figure 18. US: North America Microbial Identification Methods Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 19. Canada: North America Microbial Identification Methods Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 20. Growth Strategies in the North America Microbial Identification Methods Market
目次
Product Code: BMIRE00029664

The North America microbial identification methods market was valued at US$ 2,111.83 million in 2022 and is expected to reach US$ 3,319.78 million by 2030; it is estimated to grow at a CAGR of 5.8% from 2022 to 2030.

Increasing Food Safety Concerns Demanding for Microbial Identification Procedure Fuel the North America Microbial Identification Methods Market

Foodborne diseases (FBD) are a prevalent and expanding public health and economic problem. The prevalence of foodborne infections is influenced by recent changes in food production and processing methods and consumers' ever-evolving eating patterns. The interaction between known pathogens during infection is one of the concerns, and new difficulties have emerged in recent years. Despite the rising adoption of chemical preservatives, cold chains, and a greater understanding of microbes, foodborne illnesses are a significant public health issue for both industrialized and developing nations. The Food Security Cluster estimates that each year, ~420,000 people die, and over 600 million people-nearly one in ten people worldwide-get sick after consuming contaminated food, resulting in a loss of 33 million DALYs in June 2022.

As per the Centers for Disease Control and Prevention (CDC) 2019, every year, about 1 in 6 people in the US have a foodborne disease. Bacteria, such as Salmonella, E. Coli, Campylobacter, and Listeria, are the cause of many foodborne infections. Foodborne infections cause about 100,000 hospital admissions and 3,000 fatalities annually in the country. Additionally, every year, 4 million Canadians, or 1 in 8 of the population, become ill from contaminated food. An estimated 11,500 hospital admissions and 240 fatalities are attributed to foodborne diseases annually. Both estimates for 30 foodborne pathogens and unidentified causes of acute gastrointestinal sickness are included in the numbers. The conventional approach is cultivating bacteria using a variety of nonselective and selective enrichment techniques, followed, among other things, by biochemical confirmation. The time-to-detection is a significant limitation when testing foods, especially those with short shelf lives like fresh meat, fish, dairy products, and vegetables. Several newer detection methods use spectroscopic approaches, such as matrix-assisted laser desorption ionization-time of flight and hyperspectral imaging protocols. Thus, the increase in cases of foodborne diseases is driving the microbial identification methods market.

North America Microbial Identification Methods Market Overview

The North America microbial identification method market has experienced substantial growth in the past few years due to an upsurge in demand for accurate and rapid microbial identification across various industries such as healthcare, pharmaceuticals, food & beverages, and environmental monitoring. The growth is attributed to several factors, including the rising incidence of infectious diseases, the need for stringent quality control measures in food and pharmaceutical production, and the growing awareness of the importance of microbial monitoring in maintaining public health. The E. coli outbreak connected to frozen falafel resulted in 20 instances of sickness and five hospitalizations, according to a November 2022 update from the CDC.

Furthermore, advancements in technology, the introduction of innovative microbial identification methods, and the existence of significant players are anticipated to support the market expansion in the coming years. For instance, the BD Kiestra IdentifA system, intended to automate the preparation of microbiology bacterial identification testing, received 510(k) clearance by the FDA in January 2022. In addition, Bruker Corporation, a US-based organization, introduced the MBT Sepsityper Kit IVD in January 2021 to quickly identify more than 425 bacteria from positive blood cultures using the MALDI Biotyper CA System. Additionally, automation and artificial intelligence (AI) are pivotal in streamlining the identification process, reducing human error, and improving overall efficiency. The pharmaceutical and biotechnology sectors are major contributors to the growth of the microbial identification market in North America. The need for precise identification of microorganisms for drug development, quality control, and regulatory compliance has led to a high demand for advanced identification methods. Thus, increasing demand for accurate and rapid microbial identification across various end users, rising incidence of infectious diseases, the need for stringent quality control measures in food and pharmaceutical production, and the growing awareness of the importance of microbial monitoring in maintaining public health are a few other factors driving the market in North America.

North America Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Million)

North America Microbial Identification Methods Market Segmentation

The North America microbial identification methods market is segmented based on method, type, and country.

Based on method, the North America microbial identification methods market is segmented into genotypic, phenotypic, and proteotypic. The phenotypic segment held the largest share in 2022. The genotypic segment is further subsegmented into instruments, kits, reagents. The phenotypic segment is further subsegmented into instruments, kits, reagents. The proteotypic segment is further subsegmented into instruments, kits, reagents.

By type, the North America microbial identification methods market is segmented into bacterial identification system, microbial enumeration system, bacterial resistance identification systems, microbiology analyzer, and others. The bacterial identification system segment held the largest share in 2022.

Based on country, the North America microbial identification methods market is bifurcated into the US and Canada. The US dominated the North America microbial identification methods market in 2022.

Accelerate Diagnostics Inc, Avantor Inc, Becton Dickinson and Co, bioMerieux SA, Bruker Corp, Danaher Corp, Merck KGaA, Molzym GmbH & Co KG, Shimadzu Corp, Thermo Fisher Scientific Inc are some of the leading companies operating in the North America microbial identification methods market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Microbial Identification Methods Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis

5. North America Microbial Identification Methods Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Food Safety Concerns Demanding for Microbial Identification Procedure
    • 5.1.2 Rising Demand for Microbial Identification Methods Across Various End Users
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Automated Microbial Identification Systems
    • 5.2.2 Delay in Approval Process of New Microbial Diagnostic Test Due to Complex Regulatory Framework
  • 5.3 Market Opportunities
    • 5.3.1 Government Initiatives and Funding to Promote Microbial Identification
  • 5.4 Future Trends
    • 5.4.1 Advancements in Microbial Identification Techniques
  • 5.5 Impact Analysis:

6. Microbial Identification Methods Market - North America Market Analysis

  • 6.1 North America Microbial Identification Methods Market Revenue (US$ Mn), 2020 - 2030

7. North America Microbial Identification Methods Market - Revenue and Forecast to 2030 - by Method

  • 7.1 Overview
  • 7.2 North America Microbial Identification Methods Market Revenue Share, by Method 2022 & 2030 (%)
  • 7.3 Genotypic
    • 7.3.1 Overview
    • 7.3.2 Genotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 North America Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
      • 7.3.2.2 North America Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
  • 7.4 Phenotypic
    • 7.4.1 Overview
    • 7.4.2 Phenotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 North America Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
      • 7.4.2.2 North America Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
  • 7.5 Proteotypic
    • 7.5.1 Overview
    • 7.5.2 Proteotypic: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.5.2.1 North America Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
      • 7.5.2.2 North America Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)

8. North America Microbial Identification Methods Market - Revenue and Forecast to 2030 - by Type

  • 8.1 Overview
  • 8.2 North America Microbial Identification Methods Market Revenue Share, by Type 2022 & 2030 (%)
  • 8.3 Bacterial Identification Systems
    • 8.3.1 Overview
    • 8.3.2 Bacterial Identification Systems: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Microbial Enumeration Systems
    • 8.4.1 Overview
    • 8.4.2 Microbial Enumeration System: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Bacterial Resistance Identification Systems
    • 8.5.1 Overview
    • 8.5.2 Bacterial Resistance Identification Systems: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Microbiology Analyzers
    • 8.6.1 Overview
    • 8.6.2 Microbiology Analyzer: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: North America Microbial Identification Methods Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Microbial Identification Methods Market - Country Analysis

  • 9.1 North America
    • 9.1.1 North America Microbial Identification Methods Market, by Country
      • 9.1.1.1 US
        • 9.1.1.1.1 US: North America Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.1.2 US: North America Microbial Identification Methods Market, by Method
        • 9.1.1.1.2.1 US: North America Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.1.2.2 US: North America Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.1.2.3 US: North America Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.1.2.4 US: North America Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.1.2.5 US: North America Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.1.2.6 US: North America Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.1.3 US: North America Microbial Identification Methods Market, by Type
      • 9.1.1.2 Canada
        • 9.1.1.2.1 Canada: North America Microbial Identification Methods Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.2 Canada: North America Microbial Identification Methods Market, by Method
        • 9.1.1.2.2.1 Canada: North America Microbial Identification Methods Market, by Genotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.2.2.2 Canada: North America Microbial Identification Methods Market, by Genotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.2.2.3 Canada: North America Microbial Identification Methods Market, by Phenotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.2.2.4 Canada: North America Microbial Identification Methods Market, by Phenotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.2.2.5 Canada: North America Microbial Identification Methods Market, by Proteotypic Product, 2020-2030 (US$ Million)
        • 9.1.1.2.2.6 Canada: North America Microbial Identification Methods Market, by Proteotypic Microbe Type, 2020-2030 (US$ Million)
        • 9.1.1.2.3 Canada: North America Microbial Identification Methods Market, by Type

10. North America Microbial Identification Methods Market Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the North America Microbial Identification Methods Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Avantor Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Becton Dickinson and Co
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Danaher Corp
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 bioMerieux SA
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Merck KGaA
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Thermo Fisher Scientific Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Bruker Corp
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Shimadzu Corp
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Accelerate Diagnostics Inc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Molzym GmbH & Co KG
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Biolog Inc
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms